<DOC>
	<DOC>NCT02315274</DOC>
	<brief_summary>Hypothesis: Increased contact with the diabetes care team throughout pregnancy will lead to improved glucose control during pregnancy.</brief_summary>
	<brief_title>Pilot Study of Between Visit Interaction to Improve Glycemic Control in Pregnancy With Pre-existing Diabetes</brief_title>
	<detailed_description>Patient will have weekly contact through the Mayo Patient On-line Services to send in their blood glucose readings and to receive recommendations back regarding insulin dose changes. Information will be analyzed regarding the magnitude of change in insulin dosing and in glycemic variability.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>Adult pregnant women with type 1 diabetes utilizing either an insulin pump or multiple daily injection insulin program to manage their diabetes Female with type 1 diabetes and pregnancy EDD prior to November 15, 2014 18 years of age and older On insulin pump or multiple daily injection insulin program Signed patient consent form Female with type 1 diabetes and pregnancy under age 18 or older than age 45 Female with type 2 diabetes or gestational diabetes and pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Glycemic variability</keyword>
	<keyword>Between visit contact</keyword>
</DOC>